Hovione
HQ PT15% share
Specialty pharma CDMO; leader in inhalation API particle engineering (micronization, spray drying) and complex API manufacturing — including inhaled-grade corticosteroids.
pharmaceutical · input
Budesonide API
Inhaled corticosteroid; active ingredient in Symbicort, Pulmicort, Rhinocort. Manufactured principally by AstraZeneca (Södertälje, Sweden) for branded products and by generic API producers in India. Used in both pMDI (Symbicort aerosol) and DPI (Turbuhaler) formats. AstraZeneca conducting Phase III trials reformulating Symbicort with HFO-1234ze propellant.
3
Source countries
5
Companies
1
Goods affected
0
Claims on record
What depends on it
Goods that need this input
1 essential American goods rely on budesonide api somewhere upstream in their supply chain.
Who makes it
Supplier companies
5 companies produce budesonide api.
Symbiotec Pharmalab
HQ IN8% share
Indian corticosteroid API specialist; one of the larger merchant makers of steroid APIs incl. budesonide-class molecules.
AstraZeneca(AZN)
HQ GB
Global pharmaceutical company. Originator of Symbicort (budesonide/formoterol, pMDI and Turbuhaler DPI), Pulmicort (budesonide Turbuhaler), and Breztri. Owns proprietary Turbuhaler DPI device. Manufactures at Södertälje, Sweden (API/Turbuhaler) and Dunkirk, France (pMDI fill). In Phase III clinical trials reformulating Symbicort with HFO-1234ze in partnership with Honeywell.
Cipla(CIPLA)
HQ IN
Indian generic pharmaceutical company and the world's largest generic inhaler manufacturer by volume. Pioneer of generic salbutamol inhalers in India (1978). Manufactures generic pMDIs at scale. Received FDA final approval for generic Proventil HFA. Critical supplier during COVID-19 when global inhaler demand surged.
Sun Pharmaceutical Industries Ltd.
HQ IN
Indian pharmaceutical company (NSE: SUNPHARMA, HQ Mumbai; ~₹600B revenue); world's fourth-largest specialty generic pharmaceutical company and India's largest pharma company by market cap. Sun Pharma manufactures salbutamol sulfate API and finished albuterol inhalers (pMDI and nebulizer solution) at multiple Indian manufacturing sites, supplying US and global generic markets through its Taro Pharmaceutical US subsidiary. Sun Pharma was founded in 1983 by Dilip Shanghvi, who started with just five pharmaceutical products and a single employee; today Sun Pharma employs 36,000 people and operates 43 manufacturing sites globally. Sun Pharma's founder Dilip Shanghvi is now one of India's wealthiest individuals — his journey from a $1M startup to a $30B market cap company in 40 years is one of the defining business stories of India's pharmaceutical sector rise.